Daxor Corporation announced the payment of a dividend for 2017.
New York, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend for 2017. The Board of Directors has unanimously approved an annual dividend payment of $0.03 per share. This dividend will be paid on Friday, December 29, 2017 to Daxor shareholders of record on Thursday, December 21, 2017.
Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor’s single-use diagnostic kit. For more information regarding blood volume analysis and the Daxor BVA-100, visit Daxor’s website at www.Daxor.com.
Daxor contact information: Michael Feldschuh, President and CEO. 212-330-8505 mfeldschuh@daxor.com John Wilkens, Chief Financial Officer. 212-330-8504 jwilkens@daxor.com
